FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32966411000001102: Selexipag 1.6mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100460501000001116 Selexipag 1.6mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100460601000001117 Selexipag 1.6mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Selexipag 1.6mg tablets Is a Selexipag true Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets Is a Selexipag false Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets Has specific active ingredient Selexipag false Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets Has active ingredient Vasodilator false Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets Has specific active ingredient Selexipag true Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Uptravi 1,600microgram tablets (Janssen-Cilag Ltd) Is a True Selexipag 1.6mg tablets Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets 60 tablet Has VMP True Selexipag 1.6mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start